$410,000.00 in Sales Expected for Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) This Quarter

Wall Street analysts expect Infinity Pharmaceuticals, Inc. (NASDAQ:INFI – Get Rating) to report $410,000.00 in sales for the current quarter, according to Zacks. Five analysts have issued estimates for Infinity Pharmaceuticals’ earnings. The highest sales estimate is $550,000.00 and the lowest is $200,000.00. Infinity Pharmaceuticals reported sales of $440,000.00 in the same quarter last year, […]

Related Keywords

Florida ,United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Stevenh Holtzman , ,Polar Capital Holdings Plc ,Board Of Administration Florida Retirement System ,Zacks Investment Research ,Nasdaq ,Franklin Resources Inc ,Advisors Inc ,Sigma Securities ,Infinity Pharmaceuticals Inc ,Infinity Pharmaceuticals Company Profile Get Rating ,Infinity Pharmaceuticals ,Wall Street ,Get Rating ,Infinity Pharmaceutical ,Investment Research ,Capital Holdings Plc ,Florida Retirement System ,Franklin Resources ,Pharmaceuticals Company Profile ,Nasdaq Infi ,Infi ,Medical ,45665g30 ,Ratings ,Consensus ,